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ABSTRACT  25 
Previous studies have shown that rat intestinal IgA concentration and lymphocyte 26 
composition of the intestinal immune system were influenced by a highly enriched 27 
cocoa diet. The aim of this study was to dissect the mechanisms by which a long-term 28 
high cocoa intake was capable of modifying gut secretory IgA (S-IgA) in Wistar rats. 29 
After seven weeks of nutritional intervention, Peyer’s Patches (PPs), mesenteric lymph 30 
nodes (MLNs) and the small intestine (SI) were excised for gene expression assessment 31 
of IgA, TGF-β, CCR9, IL-6, CD40, retinoic acid receptors (RARα and RARβ), CCL25 32 
and CCL28 chemokines, pIgR and toll-like receptors (TLR) expression by real time 33 
PCR. As in previous studies, S-IgA concentration decreased in intestinal wash and fecal 34 
samples after cocoa intake. Results from the gene expression showed that cocoa intake 35 
reduced IgA and IL-6 in PPs and MLNs, whereas in SI cocoa decreased IgA, CCR9, 36 
CCL28, RARα and RARß. Moreover, cocoa-fed animals presented an altered TLR 37 
expression pattern in the three compartments studied. In conclusion, a high cocoa diet 38 
down-regulated cytokines such as IL-6, which is required for the activation of B cells to 39 
become IgA-secreting cells (IgA-SCs), chemokines and chemokine receptors, such as 40 
CCL28 and CCR9 together with RARα and RARβ, which are involved in the gut-41 
homing of IgA-SCs. Moreover, cocoa modified the cross-talk between microbiota and 42 
intestinal cells as was detected by an altered TLR pattern. These overall effects in the 43 
intestine may explain the intestinal IgA down-regulatory effect after the consumption of 44 
a long-term cocoa-enriched diet. 45 
 46 
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1. Introduction 49 
 50 
The gut associated lymphoid tissue (GALT) constitutes the most extensive and 51 
complex part of the immune system in the body. Every day it receives a huge antigenic 52 
load and it is able to distinguish between invasive pathogens and innocuous antigens 53 
from food and commensal bacteria. Structurally, the GALT is divided into organized 54 
and diffuse compartments. Organized GALT is formed by isolated lymphoid follicles 55 
(ILF) and associated lymphoid follicles or Peyer’s patches (PPs). Diffuse or effector 56 
GALT is formed by lymphocyte populations scattered across the epithelial cells 57 
(intraepithelial lymphocytes, IELs), or in the intestinal lamina propria (lamina propria 58 
lymphocytes, LPLs). Moreover, the mesenteric lymph nodes (MLNs) are part of the 59 
intestinal immune system although they are not referred to as GALT as they do not 60 
sample antigens directly [1]. M cells from PPs are specialized in luminal antigen uptake 61 
and transport towards antigen-presenting cells (APCs), which interact with 62 
interfollicular T lymphocytes or migrate towards MLNs [2]. This T cell-dependent 63 
process brings about differentiation and maturation of B cells, inducing them to become 64 
IgA+ cells and later IgA-secreting cells (IgA-SCs) [3]. Secretory-IgA (S-IgA) is the 65 
main humoral mediator in the intestine (80-90%) [4,5] and provides a first line of non-66 
inflammatory immune protection at mucosal surfaces by neutralizing microbial 67 
pathogens and exotoxins and by processing innocuous dietary antigens and commensal 68 
microbes [6,7]. S-IgA plays a key role in the maintenance of gut homeostasis and oral 69 
tolerance and its function and production is tightly regulated [2].  70 
Differentiation of B cells into IgA+ B cells occurs in PPs and, to a lesser extent, 71 
in ILF and MLNs [5]. Multiple cytokines such as transforming growth factor-β1 (TGF-72 
β1), interleukin (IL)-5, IL-6 IL-10 and IL-21 are required to IgA class switching and to 73 
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promote IgA-committed B cells to proliferate and differentiate into IgA+ B cells [8-11]. 74 
TGF-β1 plus the interaction of CD40 on B cells with CD40 ligand (CD40L) on T cells 75 
are crucial to elicit IgA class switching of activated B cells in germinal centers of PPs 76 
[12,13]. These IgA+ B cells migrate from the PPs to the draining MLNs, and home back 77 
to the intestinal lamina propria via the thoracic duct and bloodstream to further 78 
differentiate into IgA-SCs [7]. This gut-homing system requires the integrin α4β7 on 79 
activated gut lymphocytes which binds to its receptor MAdCAM-1 on endothelial cells 80 
within the intestinal mucosa[5]. Moreover, gut-homing depends on chemokines such as 81 
CCL25 and CCL28. In humans and mice, crypt epithelial cells produce CCL25, which 82 
interacts with CCR9 on B and also T cells. CCL28 is a mucosal chemokine that assists 83 
cell homing in the large and small intestine, interacting with CCR10 [14]. However, this 84 
process involving PPs is not the only one for IgA synthesis. Alternatively, IgA+ B cells 85 
can be generated within ILFs and lamina propria in a T cell-independent manner. These 86 
mechanisms involve toll-like receptors (TLRs) and activated dendritic cells (DCs) 87 
producing B-cell activating factor from the TNF family (BAFF) and a proliferation-88 
inducing ligand (APRIL) [12,15]. In any case, mucosal IgA-SCs mainly release dimers 89 
and some larger polymers of IgA, which are actively secreted to the apical surface of 90 
epithelial cells by the polymeric immunoglobulin receptor (pIgR) expressed on the 91 
basolateral surface [2].  92 
Over the last decade, an increasing interest has been focused on the 93 
identification of natural biologically active nutrients with the potential to modulate the 94 
activity of the immune system. In this regard, a vast number of studies have highlighted 95 
the health benefits of polyphenolic compounds, particularly flavonoids, due to their 96 
antioxidant properties [16]. Cocoa and cocoa-based products such as chocolate 97 
represent some of the main natural sources of dietary flavonoids, including 98 
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(-)-epicatechin, (+)-catechin and their oligomers, the procyanidins [17,18]. Although the 99 
antioxidant and immunomodulatory capacities of cocoa flavonoids have been 100 
investigated mainly in vitro [19-21], less is known about the in vivo effect of cocoa on 101 
the immune system [22]. Previous studies in our laboratory have demonstrated that a 102 
dietary intervention with cocoa is capable of modifying the composition and 103 
functionality of several lymphoid tissues in young rats, including the GALT [23,24]. In 104 
particular, a continuous cocoa intake increases the percentage of γδ T cells and reduces 105 
the proportion of Th cells in both PPs and MLNs. Cocoa intake in rats also augments 106 
B-cell proportion in PPs but depletes cells with a high capacity to secrete IgA [24]. In 107 
fact, a 10% cocoa diet decreases S-IgA concentration in the intestinal lumen of young 108 
rats, as is reflected by the lower S-IgA content in fecal samples and small-intestine wash 109 
[24].  110 
Based on the complex mechanisms of IgA regulation and the down-regulation of 111 
S-IgA after a cocoa diet, the aim of the present study was to dissect some of the 112 
mechanisms by which a long-term cocoa intake may affect IgA production. We focused 113 
on intestinal pathways and molecules involved in IgA+ B cell homing and IgA synthesis 114 
in three different compartments of the intestinal immune system PPs, MLNs and small-115 
intestine wall containing lamina propria, as representative tissues of the inductor and 116 
effector sites. 117 
118 
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2. Material and methods 119 
 120 
2.1. Chemicals 121 
   122 
The Natural Forastero cocoa (provided by Nutrexpa SA, Barcelona, Spain) used 123 
in this study contained a total polyphenol content of 10.62 mg/g with 0.83 mg/g (–)-124 
epicatechin, 0.14 mg/g (+)-catechin and 0.65 mg/g procyanidin B2. ExtrAvidin–125 
peroxidase, o-phenylenediamine dihydrochloride (OPD), bovine serum albumin (BSA) 126 
and 30% hydrogen peroxide were obtained from Sigma-Aldrich (Madrid, 127 
Spain). Mouse anti-rat IgA (A93-3), IgM (G53-238), IgG2a (B46-7), IgG2b (G15-337), 128 
IgG2c (A92-3) MAb, rat IgA, IgM, IgG1, IgG2a, IgG2b and IgG2c recombinant 129 
proteins, and biotinylated anti-rat IgA (A93-2), IgM (G53-238), IgG2a (R19-15), IgG2b 130 
(G15-337) and IgG2c (A92-1) MAb were purchased from BD Biosciences (Heidelberg, 131 
Germany). Anti-rat IgG1 (MRG1-58) was obtained from BioLegend (San Diego, CA) 132 
and peroxidase-conjugated anti-rat Ig MAb was provided by DakoCytomation 133 
(Glostrup, Denmark). RNAlater® was purchased from Ambion (Applied Biosystems, 134 
Austin, TX).   135 
 136 
2.2. Animals and experimental design 137 
 138 
Three-week-old female Wistar rats were obtained from Harlan (Barcelona, 139 
Spain) and housed in cages under conditions of controlled temperature and humidity in 140 
a 12:12 light-dark cycle. After 6 days of acclimatization, the rats weighing 66-74 g were 141 
randomly assigned to two dietary groups (n=7 each group): the reference group which 142 
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was fed with a standard diet, and the cocoa group which received chow containing 10% 143 
(w/w) cocoa for 7 weeks.    144 
 145 
The AIN-93G formulation [25] (Harlan) was used as the control standard diet. The 146 
cocoa diet was produced from a modification of the AIN-93G formula, as previously 147 
described [24]. In brief, we used a basal mix (Harlan) in which the proportion of 148 
proteins, carbohydrates and lipids had been modified in such a way that the addition of 149 
10% cocoa (100 g/kg) resulted in a final isoenergetic diet with the same macronutrient 150 
composition as the AIN-93G diet. Animals were given free access to water and chow ad 151 
libitum, and body weight and food intake were monitored throughout the experiment. 152 
The study was performed according to the criteria outlined by the Guide for the Care 153 
and Use of Laboratory Animals. Experimental procedures were reviewed and approved 154 
by the Ethical Committee for Animal Experimentation of the University of Barcelona. 155 
 156 
2.3. Sample collection 157 
 158 
 Fecal and sera samples were collected before the diet (week 0), in the middle 159 
(week 3.5) and at the end of the study (week 7) and kept at –20ºC for further 160 
immunoglobulin quantification. At the end of the dietary intervention, the rats were 161 
anesthetized intramuscularly with ketamine/xylazine. MLNs were removed in aseptic 162 
conditions for PCR analysis. The small intestine (SI) was excised, divided into two 163 
fragments and carefully flushed with sterile 0.9% NaCl solution to remove fecal 164 
content. The distal fragment of the SI was opened lengthwise and PPs were excised for 165 
PCR analysis, as well as a maximum of 30 mg of tissue corresponding to distal 166 
jejunum/proximal ileum without PPs. The remaining distal fragment of the SI was used 167 
to obtain the gut wash for IgA determination as previously described [24]. All tissue 168 
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samples for PCR were immediately immersed in RNAlater® and incubated at 4 ºC 169 
overnight before storing at -20 ºC. 170 
 171 
2.4. Fecal homogenate obtention 172 
 173 
Fecal samples were dried for 70 min at 37 ºC in a thermostatically controlled 174 
incubator and for 30 min at room temperature (RT) before being weighed. Thereafter, 175 
fecal samples were diluted in PBS (20 mg/ml) and homogenized using a Polytron 176 
(Kinematica, Lucerne, Switzerland). Homogenates obtained were then centrifuged (500 177 
g, 15 min, RT), and supernatants were frozen at −20 °C until ELISA IgA quantification. 178 
 179 
2.5. Immunoglobulin quantification in serum, gut wash and feces by ELISA 180 
 181 
S-IgA and S-IgM levels in gut wash and feces, and serum IgA, IgM, IgG1, 182 
IgG2a, IgG2b, IgG2c concentrations were quantified by ELISA. Ninety-six-well 183 
polystyrene plates (Nunc MaxiSorp, Wiesbaden, Germany) were coated with mouse 184 
anti-rat IgA, IgM, IgG1, IgG2a, IgG2b or IgG2c MAb (2 µg/ml in PBS) and incubated 185 
in a humidified chamber overnight. Thereafter, the remaining binding sites were 186 
blocked with PBS containing 1% BSA (PBS-BSA, 1 h, RT). The plate was washed 187 
three times with PBS containing 0.05% Tween 20 (PBS-Tw) and once with PBS; then 188 
appropriate diluted samples and standards in PBS–Tw–BSA were added (3 h, RT). 189 
After washing, biotin-conjugated mouse anti-rat IgA, IgM, IgG1, IgG2a, IgG2b or 190 
IgG2c MAb were added (1 µg/ml in PBS–Tw–BSA, 2 h, RT). Thereafter, peroxidase-191 
conjugated ExtrAvidin (4 µg/ml in PBS–Tw–BSA) was incubated for 30 min. Lastly, 192 
OPD and H2O2 were added for the detection of bound peroxidase. The reaction was 193 
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stopped by adding 3M H2SO4. Absorbance was measured on a microtiter plate 194 
photometer (Labsystems, Helsinki, Finland) at 492 nm. Data were interpolated by 195 
means of Multiskan Ascent v.2.6 software (Thermo Fisher Scientific S.L.U, Barcelona, 196 
Spain) into the standard curves, and expressed as µg/mL in sera, gut washes and fecal 197 
samples.  198 
 199 
2.6. Assessment of RNA gene expression by Real Time PCR 200 
 201 
For RNA isolation, tissue samples in RNA later® were transferred into lysing 202 
matrix tubes (MP Biomedicals, Illkirch, France) containing an appropriate buffer and 203 
homogenized in a FastPrep®-24 instrument (MP Biomedicals) for 40 s. Lysates were 204 
centrifuged for 3 min at 12000 g to eliminate excess tissue debris in and transferred into 205 
new tubes. RNA was isolated by the RNAeasy® mini kit (Qiagen, Madrid, Spain) 206 
following manufacturer’s recommendations. RNA was quantified with a NanoDrop 207 
spectrophotometer and NanoDrop IVD-1000 v.3.1.2 software (NanoDrop Technologies, 208 
Wilmington, DE). The Agilent 2100 Bioanalyzer with the RNA 6000 LabChip 1 kit 209 
(Agilent Technologies, Madrid, Spain) was used to provide an RNA integrity number 210 
(RIN) for each sample.  211 
Four µg of total RNA were reverse-transcribed in a thermal cycler PTC-100 212 
using random hexamers and TaqMan® Reverse Transcription Reagents (Applied 213 
Biosystems, AB, Weiterstadt, Germany). A final volume of 1 µL was used to confirm 214 
the reaction of each sample by conventional PCR using rat β-actin primers and 215 
conditions previously established in our laboratory [26].  216 
Specific PCR TaqMan® primers and probes (Applied Biosystems, AB, 217 
Weiterstadt, Germany) were used to measure Iga (331943, made to order), Tgfb1 218 
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(Rn00572010_m1, inventoried (I)), Il5 (Rn99999143_mH, inventoried), Il6  219 
(Rn01410330_m1), Cd40 (Rn01423583_m1,I), Rara (Rn00580551_m1, I), Rarb 220 
(Rn01537835_m1, I), Ccr9 (Rn00597283_m1, I), Tlr2 (Rn02133647_s1, I), Tlr4 221 
(Rn00569848_m1, I), Tlr7 (Rn01771083_s1, I), Tlr9 (Rn01640054_m1, I), Pigr 222 
(Rn00562362_m1, I), Ccl25 (Rn0143351_m1, I) and Ccl28 (Rn00586715_m1, I). 223 
Quantitative PCR assays were performed in duplicate for each sample using an ABI 224 
PRISM®7700 Sequence Detection System (AB). Quantification of the genes of interest 225 
was normalized to the housekeeping genes Hprt1 (Rn01527840_m1, I) and Gusb 226 
(Rn00566655_m1, I). The amount of target mRNA relative to the endogenous control 227 
expression and relative to values from the reference group was calculated using the 228 
2-∆∆Ct method, as previously described [27], where Ct is the cycle number at which the 229 
fluorescence signal of the PCR product crosses an arbitrary threshold set within the 230 
exponential phase of the PCR and ∆∆Ct= [(Cttarget (unknown sample) – Ctendogenous control (unknown 231 
sample))] – [(Cttarget (reference sample) – Ctendogenous control (reference sample))]. Results are expressed as 232 
the mean ± SEM of the percentage of these values for each experimental group 233 
compared with its reference age group, which represents 100% gene expression. 234 
 235 
2.7. Statistical analysis 236 
 237 
The software package SPSS 16.0 (SPSS, Inc., Chicago, IL) was used for 238 
statistical analysis. The data were analyzed by the Mann–Whitney U test. A P value of 239 
< 0.05 was considered statistically significant.  240 
241 
 11
3. Results 242 
 243 
3.1. Effect of cocoa diet on body weight 244 
 245 
 Body weight and chow intake were monitored throughout the study (3 times per 246 
week). The growth of animals with the cocoa diet was slower than that of the reference 247 
animals (P<0.01, Figure 1). This effect was not associated with a lower chow intake 248 
because food intake was similar between both groups (data not shown) as reported 249 
previously [23,24,28]. 250 
 251 
3.2. Effect of cocoa diet on serum immunoglobulins 252 
 253 
Concentrations of IgG1, IgG2a, IgG2b, IgG2c, IgM and IgA were quantified in 254 
serum before, in the middle and at the end of dietary intervention. Data from the 255 
experimental groups are summarized in Figure 2. At the end of the study, the 256 
predominant IgG isotype present in the reference animals’ serum was IgG2a (~600 257 
µg/mL), followed by IgG2b (~370 µg/mL), IgG1 (~170 µg/mL) and IgG2c (~115 258 
µg/mL). Serum IgM and IgA concentrations were about 635 µg/mL and 5 µg/mL, 259 
respectively. A long-term cocoa diet significantly modified serum immunoglobulin 260 
concentrations: IgG2b, IgM and IgA concentrations being ~50% lower than values in 261 
the reference animals at the end of the study (Fig. 2C, 2E, 2F, P < 0.05). This reduction 262 
was already evident for IgG2b and IgM after 3.5 weeks of cocoa intake. Moreover, 263 
cocoa intake tended to decrease serum IgG1 and IgG2c concentrations (Fig. 2A and 264 
2D).The cocoa diet did not modify IgG2a concentration after a 7-week intake but we 265 
found an increase of this isotype in the middle of the study (Fig. 2B, P < 0.05).  266 
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 267 
3.3. Effect of cocoa diet on intestinal immunoglobulins 268 
 269 
Intestinal IgM and IgA production was quantified by means of evaluation in 270 
feces before and after 7 weeks of cocoa intake, and in intestinal wash at the end of the 271 
study (Figure 3). The cocoa diet produced a decrease of S-IgA and S-IgM in intestinal 272 
wash (Fig. 3A, P < 0.05). Fecal IgA concentration increased according to age in the 273 
reference group, and that increase was inhibited by the dietary intervention with cocoa 274 
(Fig. 3B, P < 0.05). S-IgM was not detected in fecal samples. 275 
 276 
3.4. Expression of constitutive genes 277 
  278 
Expression levels of two commonly used housekeeping genes, Gusb and Hprt1, 279 
were analyzed in all tissues of both groups. Ideally, all cell types and tissues should 280 
constitutively express housekeeping genes independently of experimental conditions 281 
and they should not be affected by interventional, environmental or regulative factors. 282 
We found that Gusb expression was relatively homogenous among samples whereas 283 
Hprt1 expression fluctuated regardless of the diet (data not shown). This result 284 
prompted us to discard Hprt1 as a normalizing gene and results were referred to Gusb 285 
expression (Figure 4). The coefficients of variation for both inter- and intrassay 286 
determinations were < 2 and 1 % respectively, indicating the high reproducibility of the 287 
assay and that dispersion among samples within the same group was due to animal 288 
physiological variations.   289 
 290 
291 
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3.5. Effect of cocoa diet on genes related to IgA class switching and secretion 292 
 293 
Iga, Tgfb1, Il6, Il5 and Cd40 expression was assessed in SI, PPs and MLNs after 294 
7 weeks of cocoa intake (Fig. 4A, 4B, 4C). Additionally, Pigr expression was also 295 
analyzed in SI. In cocoa-fed animals, IgA was down-regulated in both PPs and SI (P < 296 
0.05) and tended to decrease in MLNs. The cocoa diet did not significantly modify 297 
Tgfb1 expression in any of the tissues considered; however, Il6 was reduced ∼95% in 298 
MLNs (P < 0.05) and tended to decrease in the PPs of the cocoa group animals whereas 299 
Il6 expression was not detected in the SI. Il5 expression was also too low to be detected 300 
in the analyzed tissue samples. Cocoa intake reduced Cd40 expression in SI (P < 0.05) 301 
but Cd40 was not modified, either in PPs or in MLNs. Pigr tended to be reduced in the 302 
SI from cocoa-fed rats. 303 
 304 
3.6. Effect of cocoa diet on genes associated with IgA-secreting cell homing 305 
 306 
Rara, Rarb and Ccr9 were analyzed in PPs, MLNs and SI (Fig. 4D, 4E, 4F). 307 
Moreover, Ccl25 and Ccl28 expression was also studied in SI. The cocoa diet produced 308 
that Rara was up-regulated 5-fold in PPs (P < 0.05) and tended to be augmented in 309 
MLNs; however, this gene was decreased ~70% in the SI of cocoa-fed animals (P < 310 
0.05). With regards to Rarb, the cocoa group showed a 5-fold expression increase in 311 
MLNs (P < 0.05) whereas it decreased in PPs and SI (P < 0.05 in SI). Cocoa intake did 312 
not alter Ccr9 expression in PPs or MLNs but reduced its expression in SI (P < 0.05). 313 
With regards to chemokine gene expression in SI, the cocoa diet significantly reduced 314 
Ccl28 expression (75%, P < 0.05) but did not significantly modify Ccl25 expression. 315 
 316 
 14
3.7. Effect of cocoa on TLR gene expression.  317 
 318 
Expression of Tlr2, Tlr4, Tlr7 and Tlr9 was assessed in PPs, MLNs and SI (Fig. 319 
4G, 4H, 4I). Tlr2 was decreased up to ~ 80% in the PPs of cocoa-fed animals (P < 0.05) 320 
as well as in MLNs, but increased in SI. A similar pattern was also found for Tlr7 321 
expression. Tlr4 expression augmented ~ 2-fold in PPs (P < 0.05), was not modified in 322 
MLNs whereas it was reduced in the SI of cocoa group rats (P < 0.05). Cocoa intake 323 
drastically increased Tlr9 expression in both PPs and MLNs (P < 0.05).  324 
325 
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4. Discussion 326 
 327 
In previous studies, we reported that cocoa flavonoids possess in vitro and in 328 
vivo modulator effects on the immune system [24,29-31]. Specifically, we found that a 329 
cocoa-enriched diet in young rats over 3 weeks produced a down-modulator effect on 330 
intestinal IgA content [24]. Similarly, here we have found that a high and continuous 331 
cocoa intake reduced intestinal IgA concentration. The intestinal IgA drop as a result of 332 
cocoa intake suggests that a cocoa diet could influence specific mechanisms involved in 333 
IgA production located at the intestinal site. The present study is focused on the gene 334 
expression of some molecules related to the IgA synthesis, IgA-SCs, and gut cell 335 
homing and lumen secretion in order to achieve an understanding of some pathways 336 
within the complex intestinal immune system that could be involved in intestinal IgA 337 
modulation by cocoa. 338 
 Firstly, we focused on the main pathway that brings about differentiation and 339 
maturation of B cells inducing them to become IgA-SCs, the T cell-dependent process 340 
that takes place in either PPs or MLNs, inductive sites of the intestinal immune system 341 
[3]. This process depends on cytokines such as TGF-β1 and IL-6, among others [7,10]. 342 
The results obtained in the present study showed no significant changes in TGF-β1 343 
whereas IL-6 was depleted in the PPs and MLNs of animals that were fed cocoa. As 344 
IL-6 is secreted by DCs in PPs [15] we can suggest that some cocoa compounds 345 
reaching the intestine could act on these cells and modulate the secretion of IL-6 346 
involved in IgA+ B cell differentiation. In addition, the interaction between T and B 347 
cells through CD40L-CD40 is crucial to elicit IgA class switching on activated B cells 348 
in the germinal centers of PPs [12]. The expression of CD40 did not change in either 349 
PPs or MLNs after cocoa intake, which is in accordance with previous studies that have 350 
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shown that a cocoa diet increases the proportion of B cells in PPs [24]. Therefore, 351 
although the cocoa diet decreased soluble factors, such as IL-6, which promote IgA+ B 352 
cells, it seems that it had no influence on the direct interaction between T and B cells. 353 
However, lower IgA gene expression was found in PPs and MLNs, which could 354 
eventually mean that there would be less differentiation in IgA+ B cells, and/or lower 355 
IgA synthesis ability in these compartments. This suggestion agrees with previous 356 
findings that have shown that, after a cocoa diet, although the total number of IgA-SCs 357 
does not change, the number of high-capacity IgA-SCs in PPs decreases [24].  358 
Physiologically, after the maturation process in the inductive sites, i.e. PPs and 359 
MLNs, activated IgA+ B cells migrate from there and home back to the intestinal 360 
lamina propria, as the effector site, to further differentiate into IgA-SCs [7]. This 361 
gut-homing system requires the expression of the chemokine receptor CCR9 on IgA+ B 362 
cells which binds to its ligand CCL25, thus promoting cell recruitment to the intestinal 363 
lamina propria [14]. We found that the cocoa diet did not modify CCR9 expression in 364 
either the PPs or MLNs but reduced it in the SI. Interestingly, CCL25 gene expression 365 
was augmented in this last tissue in cocoa-fed animals. These results suggest that 366 
molecules involved in the gut homing of IgA-SCs would be modified not in the 367 
inductive sites but in the effector tissues, and it seems that small intestine lamina propria 368 
increased CCL25 in an attempt to strongly attract the reduced number of CCR9-369 
expressing cells. On the other hand, DCs from PPs and intestinal lamina propria have 370 
been shown to induce CCR9 expression on IgA+ B cells by means of retinoic acid (RA) 371 
production [32]. The action of RA is mediated by its ligation to RA nuclear receptors 372 
such as RARα and RARß [33]. Here we found that the cocoa diet up-modulated RARα 373 
and RARß gene expression in PPs and MLNs, respectively, but both were reduced in SI. 374 
This last result agrees with the decreased CCR9 gene expression found in SI, and it 375 
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allows us to postulate that lower CCR9 values in intestinal lamina propria could be a 376 
consequence of a decrease in the expression of RARα and RARß in B cells present in 377 
this compartment. The meaning of the up-regulation of RARα and RARß in the 378 
inductive sites, where CCR9 expression was maintained after diet intervention, remains 379 
to be elucidated. On the other hand, we have found that SI from cocoa-fed rats had 380 
reduced values of CCL28 gene expression, a chemokine produced by epithelial cells 381 
which selectively attracts IgA+ B cells [14]. Taking together all these results, we suggest 382 
that a high cocoa diet induces a lower number of IgA+ B cells reaching the intestinal 383 
lamina propria by the down-modulation of chemokines (such as CCL28, involved in 384 
homing both to the small and the large intestine) or chemokine receptors (such as 385 
CCR9, mediated in part by the down-regulation of RAR), although some mechanisms in 386 
the own gut lamina propria work efficiently (CCL25 synthesis). 387 
After the homing and differentiation processes, IgA-SCs of intestinal lamina 388 
propria release dimmers or larger polymers of IgA which are actively secreted to the 389 
apical surface of epithelial cells by the polymeric immunoglobulin receptor (pIgR) 390 
expressed on the basolateral surface [2]. Cocoa-fed animals showed a lower expression 391 
of IgA and CD40 in SI, and a variable expression of pIgR. These results allow us to 392 
hypothesize that after cocoa intake intestinal lamina propria contained lower numbers of 393 
activated B cells (CD40+) and IgA-SCs, which agrees with the reduction of homing and 394 
activation mechanisms presented above. Nevertheless, the way IgA was transported 395 
across the epithelial layer mediated by the pIgR was not significantly affected by this 396 
dietary intervention.  397 
In addition to the T-dependent way to secrete IgA referred to so far, IgA+ B 398 
cells can be alternatively generated in a T cell-independent manner which involves TLR 399 
signaling, among others ways [15]. Cocoa-fed animals showed changes in the 400 
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expression of at least all the considered TLRs: TLR2, which recognizes components 401 
from gram-positive bacteria; TLR4, which recognizes LPS or gram-negative bacteria; 402 
TLR7, which is found in endosomes and recognizes single-stranded RNA from viruses, 403 
and TLR9, wich is also found in endosomes and acts as a receptor for CpG in bacterial 404 
and viral DNA [34]. A high and continuous cocoa diet produced an up-regulation of 405 
TLR4 and TLR9 and a down-regulation of TLR2 and TLR7 in PPs and MLNs. 406 
Conversely, in SI, cocoa-fed animals showed lower values for TLR4 and TLR9 and a 407 
higher expression of TLR2 and TLR7. TLRs are expressed preferentially in tissues that 408 
are in constant contact with microorganisms [34,35] and changes in the TLR expression 409 
could reflect changes in the intestinal microbiota and/or its relation with intestinal 410 
immune cells [36]. Therefore, the overall change in the TLR expression found here, 411 
whatever the meaning of contradictions between the inductor and effector sites, could 412 
be a consequence of changes in intestinal microbiota induced by the cocoa-enriched 413 
diet. In fact, a recent study has shown in humans that the daily consumption of a cocoa 414 
beverage rich in flavanols significantly increased the growth of Lactobacillus spp. and 415 
Bifidobacterium spp and decreased that of Clostridium histolyticum group [37]. 416 
Similarly, Thus wine-treated rats show gut prevalence of Bacteroides, Lactobacillus and 417 
Bifidobacterium [38] and pigs administered with tea polyphenols increase intestinal 418 
Lactobacillus [39]. Moreover, berries and their phenolics selectively inhibit the growth 419 
of pathogenic bacteria in humans [40,41]. In consequence, it seems that the 420 
consumption of flavanol-rich food seems to exert prebiotic actions [37, 42]. In any case, 421 
further studies must determine the microbiota composition of rats fed a cocoa diet. On 422 
the other hand, it would be interesting to know the relation, if any, between changes in 423 
the TLRs of the three tissues and the IgA-secreting function of the intestinal immune 424 
system. It has been reported that TLR4 signaling in the intestinal epithelial cells 425 
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promotes the recruitment of B cells to the lamina propria by means of CCL28 and 426 
CCL20 chemokines [43]. Moreover, TLR4 expression has been directly correlated to a 427 
higher number of IgA-SCs in the lamina propria and increased IgA in the feces of 428 
transgenic mice that express a constitutively active form of TLR4 on intestinal epithelial 429 
cells [34,43]. As we found that a high cocoa diet produced a down-regulation of TLR4 430 
and also CCL28 in SI, it could be suggested that TLR alterations could be involved in 431 
the lower recruitment of IgA-secreting cells to the intestinal lamina propria. Other 432 
studies have shown the effect of polyphenols on TLR expression. Thus, 433 
epigallocatechin-gallate (EGCG) reduces TLR4 gene expression on macrophages in 434 
vitro [44], and an interventional study with orange juice with hesperidin and naringenin 435 
produced a reduction in TLR2 and TLR4 mRNA and protein expression in PBMC [45]. 436 
Moreover, EGCG and curcumin have been shown to be able to block TLR4 437 
glycosilation and homodimerization [46,47], in both cases inhibiting the activated 438 
downstream molecules. In addition, two downstream signaling adaptors of TLRs, 439 
MyD88 and TRIF proteins, have been specifically inhibited by resveratrol [48], luteolin 440 
[49], EGCG [50] or curcumin [47]. Thus, we cannot disregard the effect of cocoa 441 
flavonoids on TLR-related pathways, which could contribute to their down-regulatory 442 
role on IgA. The potential bioactivity of flavonoids depend on their bioavailability and, 443 
while monomeric flavonoids are rapidly absorbed in the small intestine, the polymeric 444 
forms -present in high proportion in cocoa- reach intact into the colon where they are 445 
metabolized by the intestinal microbiota into various phenolic acids [51]. In this sense, 446 
several dietary interventions have evidenced the accessibility of cocoa flavonoids in the 447 
large intestine [52,53], where they or their metabolites might exert a modulatory effect 448 
on microbiota and, consequently, on the TLR expression.  449 
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 On the other hand and in addition to the effects on the gut, the high cocoa diet 450 
reduced IgG, IgM and IgA serum concentrations in Wistar rats, in agreement with 451 
previous studies [31]. Furthermore, the influence of the cocoa intake on IgG depended 452 
on the isotype, IgG2b being the most reduced by the diet. As IgG2b isotype is 453 
associated with Th1 immune response in rats [54-56], it seems that the cocoa diet 454 
tended to reduce Th1 immune responses. This suggestion agrees with the anti-455 
inflammatory properties shown in cocoa intake [57]. Nevertheless, it still remains to be 456 
seen how a cocoa diet acts on pathways involved in the production of each IgG isotype. 457 
On the other hand, there are also unknown mechanisms that decrease serum IgM and 458 
IgA, although these reductions could partially reflect the reduction of mucosal 459 
immunoglobulin synthesis. 460 
Finally, the 10% cocoa diet produced an attenuating effect on the body weight 461 
increase of the animals, despite the food consumption was similar in all experimental 462 
groups. This effect has been reported in previous studies [23,24] and could be attributed 463 
to the gene regulation of mechanisms implicated in the adipose tissue synthesis, as 464 
described elsewhere [28]. 465 
 In summary, we have demonstrated by using a continuous and high cocoa-466 
enriched diet in Wistar rats that compounds present in cocoa interact with mechanisms 467 
involved in intestinal IgA production, leading to a lower IgA secretion. These 468 
mechanisms comprise cytokines produced by DCs, such as IL-6, required in the 469 
induction site (PPs and MLNs) and chemokines and their receptors, such as CCL28 and 470 
CCR9 together with RARα and RARβ, needed for gut homing. Moreover, a high cocoa 471 
diet also modified the cross-talk between microbiota and the intestinal cells, as shown 472 
by an altered TLR pattern. Finally, all these changes seem to produce a lower number of 473 
IgA-SCs and/or a lower ability to synthesize this antibody in the small intestine. Further 474 
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studies must be considered to explore the precise compounds and amount of cocoa 475 
responsible for this action. 476 
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FIGURE LEGENDS 623 
 624 
Figure 1. Body weight of female Wistar rats fed a cocoa (●) or standard (○) diet over 7 625 
weeks. Data are means ± SEM (n = 7). Cocoa intake resulted in a lowered growth curve 626 
from day 8 and until the end of the study (P < 0.01). 627 
 628 
Figure 2. Effect of a cocoa enriched diet on serum IgG1(A), IgG2a (B), IgG2b (C), 629 
IgG2c (D), IgM (E) and IgA (F) isotypes. Black bars correspond to the cocoa diet and 630 
white bars correspond to the standard diet. Each bar represents the mean ± SEM (n =5–631 
7).*P < 0.05  632 
   633 
Figure 3. Effect of the cocoa-enriched diet on S-IgA and S-IgM in gut wash (A), and on 634 
S-IgA in feces (B). Gut wash values are related to those found in the reference group 635 
which are considered as 100%.  Black bars correspond to the cocoa diet and white bars 636 
correspond to the standard diet. Each bar represents the mean ± SEM (n =6–7). 637 
*P < 0.05 638 
 639 
Figure 4. Expression of genes associated with IgA synthesis, secretion, switching, 640 
intestinal homing and TLRs in PPs (A, D, G), MLNs (B, E, H) and SI (C, F, I) after the 641 
cocoa diet. Expression levels were normalized using the expression of Gusb as the 642 
endogenous housekeeping gene. Black bars correspond to the cocoa diet and white bars 643 
correspond to the standard diet. Each bar represents the mean ± SEM (n =5–7) of the 644 
percentage of the cocoa group compared with the reference group, which represents 645 
100% gene expression. *P < 0.05. 646 
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